HIMS News

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

HIMS DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – HIMS

HIMS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Hims & Hers Health, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

HIMS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Hims & Hers Health, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

DEADLINE ALERT for YSS, HIMS, UNCY, and PZZA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately

Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm